Join the 12th BiG IMPACT Annual Conference in Shanghai for two days of conversations connecting biotech founders, scientists, investors, and industry leaders across China and the global life-science community.
Select your ticket type above. Full program, workshops, and event details are available below.
Couldn't load pickup availability
October 23–24, 2026 · Shanghai, China
Global Vision. Innovation Transcends Borders.
Hosted by BiG, the Biomedical Innovation Group, this meeting brings together people working across biomedical research, clinical development, and industry. The main program begins Friday afternoon and continues throughout Saturday.
For overseas biotech founders, R&D leaders, investors, and business development teams: meet China's biomedical innovation community directly, examine how research moves toward clinical development, and explore where cross-border collaboration may be possible.
Gregory Verdine, Harvard scientist and serial biotech entrepreneur, and Peter Kolchinsky, founder of RA Capital Management, join leading voices from China.
Xiaodong Wang (NIBS; BeOne Medicines), Yongkui Sun (innovative-drug R&D), Bai Lu (Shanghai Shangsi Institute), and clinician-scientist Huji Xu address entrepreneurship, clinical translation, and innovation infrastructure.
Science2Startup (S2S), backed by RA Capital and other venture investors, comes to China with a focus on translating frontier research into biotech startups.
Young BiG's Pick presents selected emerging Chinese biotech ventures and the next generation of research-led companies.
Parallel sessions span large molecules, small molecules, new modalities, autoimmune disease, and CNS research.
Policy, investment, and MNC business-development discussions put science in the context of capital, regulation, and cross-border collaboration.
BiG is a nonprofit biomedical innovation community founded by biotech entrepreneurs, scientists, clinical experts, and CRO/CDMO leaders. Its annual IMPACT meeting creates space for scientific exchange, translational research, and dialogue between research and industry communities.
BiG brings together people from biotech, pharma, research, and the organizations that help new ideas advance. These are selected member organizations from the broader BiG community.
A selection from BiG's member community. These organizations are not presented as sponsors of this conference.
Explore two days of conversations, panels, and parallel tracks. All times are local to Shanghai. Program and speakers are subject to change.
Group 1 · The journey of scientific founders
Xiaodong Wang · Gregory Verdine
Group 2 · Innovation infrastructure, from preclinical to clinical development
Yongkui Sun · Huji Xu
Group 3 · Global industry strategy and the innovation ecosystem
Bai Lu · Fangning Zhang
Panel 1 · Challenges and opportunities in translational science
Invited perspectives from biotech, pharma, research, investment, and regulation.
Panel 2 · The biopharma social contract and US–China collaboration
Chaired by Peter Kolchinsky, with invited industry, clinical, economic, and payer perspectives.
Track 1 · Cutting-edge innovative drug molecules
Large molecule drugs: a competitive landscape (Chair: Chengbing Wu).
Frontier small molecules and new modalities (Chair: Lianshan Zhang).
Track 2 · Young BiG Summit
S2S Global Research Translation Project Grand Prix: winner presentation (Chairs: Josh Resnick and a representative from RA Capital Management).
Young BiG's Pick (Chair: Eric Yu).
Track 3 · Breakthrough therapies and disease frontiers
Breakthrough autoimmune therapies (Chair: Ling Zhou).
Next-generation CNS (Chair: Joan Shen).
Track 4 · Policy and capital
Policy impact on the biopharma industry (Chair: Ying Yang).
New investment trends and strategies (Chair: Jieyu Zou).
MNC business development collaborations (Chair: Tong Zhang).
Individual session times within each program block are not yet available.
October 22 full day · October 23 morning
Invitation-only, small-group workshops offer space for focused discussion before the main conference.
China's clinical resources, policy and clinical-science trends, and cross-border development practices.
Domestic AI drug developers, frontier pipelines, and emerging discovery models.
Traditional BD partnerships versus NewCo models, with cases of Chinese innovators expanding globally.
Workshop access: Participation is by invitation and requires separate confirmation. Please check eligibility when registering.
Conference venueHilton Shanghai Zhangjiang Science City
No. 1398 Haike Road, Pudong New Area
Shanghai, China
The main program runs Friday, October 23, in the afternoon and Saturday, October 24, throughout the day. All times shown here are local to Shanghai.
Workshops are invitation only and require separate confirmation. Please check eligibility when registering.
Program details and speakers may change.
Stay Connected
Get speaker announcements, agenda updates, biotech insights from China, and future opportunities to connect with the BiG community.
Conference updates presented with support from Direct2Lab, BiG IMPACT's North America and overseas promotion sponsor.
North America & Overseas Promotion Sponsor
WHY DIRECT2LAB SUPPORTS BIG IMPACT
At Direct2Lab, we believe supporting science means more than supplying what happens at the bench.
Every day, we work to make essential lab supplies easier to access so researchers can spend less time managing friction and more time moving their work forward. But progress also depends on something bigger: the exchange of ideas, stronger scientific communities, and meaningful connections between researchers, founders, companies, and institutions.
As the North America and overseas promotion sponsor of the 12th BiG IMPACT Annual Conference, Direct2Lab is proud to help bring these conversations to a broader global life-science community — connecting Boston and North America with Shanghai and the people shaping the future of biotech around the world.
Because when science connects, science moves.
Direct2LabMove Science Forward.
About Direct2LabProduct Comparison |
| Type |
| Material |
| Use Case |
| Capacity / Size Options |
| Sterilization |
| Shape / Design |
| Durability |
| Compatibility |
| Key Benefit |
| Recommended For |
| — | — | — | — | — | — | — | — | — | — |
